Neopterin: Marker of coronary artery disease activity, severity and/or extent in patients with clinically stable angina?
Authors:
- Hannes F. AlberHAHannes F. Alber
- Maria WanitschekMWMaria Wanitschek
- Christina DuftnerCDChristina Duftner
- Jakob DoerlerJDJakob Doerler
- Michael SchirmerMSMichael Schirmer
- Alois SuessenbacherASAlois Suessenbacher
- Matthias FrickMFMatthias Frick
- Wolfgang DichtlWDWolfgang Dichtl
- Otmar PachingerOPOtmar Pachinger
- Franz WeidingerFWFranz Weidinger
- 24 September 2010
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 144 (1) , 75-76
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Neopterin, CD4+CD28− lymphocytes and the extent and severity of coronary artery diseaseInternational Journal of Cardiology, 2009
- Neopterin — Marker of coronary artery disease activity or extension in patients with chronic stable angina?International Journal of Cardiology, 2009
- Ethical authorship and publishingInternational Journal of Cardiology, 2009
- High‐density lipoprotein cholesterol, C‐reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiographyEuropean Journal of Clinical Investigation, 2008
- Multiple inflammatory markers in patients with significant coronary artery diseaseInternational Journal of Cardiology, 2007
- Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectorisEuropean Heart Journal, 2005
- Markers of Inflammation and Rapid Coronary Artery Disease Progression in Patients With Stable Angina PectorisCirculation, 2004
- Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromesHeart, 2004